Nonclassic steroid 21-hydroxylase deficiency is a frequent, relatively mild disorder of cortisol biosynthesis, characterized by variable signs of postnatal androgen excess. It is inherited as an allelic variant of the gene designated CYP21B, which encodes 21-hydroxylase. CYP21B is located in the HLA histocompatibility complex, and a "nonclassic" allelic variant is often associated with characteristic HLA antigens--B14,DR1. We cloned and analyzed the CYP21B gene from a patient homozygous for HLA-B14,DR1 who had nonclassic 21-hydroxylase deficiency. Five deviations from the normal genetic sequence of CYP21B were found, but only one appeared likely to affect the functional integrity of the protein: codon 281, GTG, encoding valine, was changed to TTG, leucine. We constructed an oligonucleotide probe corresponding to the mutant DNA sequence surrounding codon 281 and hybridized the probe with DNA samples digested with the restriction endonuclease Taql. Samples from eight patients with nonclassic 21-hydroxylase deficiency who had the haplotype HLA-B14,DR1 contained a hybridizing fragment 3700 base pairs long, indicating the presence of the valine-281 mutation in the CYP21B gene. In contrast, unaffected subjects and one patient with nonclassic deficiency who did not have HLA-B14,DR1 had no evidence of this mutation. We conclude that the mutation in codon 281 is a consistent molecular genetic marker for nonclassic 21-hydroxylase deficiency associated with HLA-B14,DR1.
Source Information
Division of Pediatric Endocrinology, Cornell University Medical College, New York, NY 10021.
This article has been cited by other articles:
Araujo, R. S., Mendonca, B. B., Barbosa, A. S., Lin, C. J., Marcondes, J. A. M., Billerbeck, A. E. C., Bachega, T. A. S. S.
(2007). Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
92: 4028-4034
[Abstract][Full Text]
Gidlof, S., Wedell, A., Nordenstrom, A.
(2007). Gestational Age Correlates to Genotype in Girls with CYP21 Deficiency. J. Clin. Endocrinol. Metab.
92: 246-249
[Abstract][Full Text]
Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., Persson, B.
(2006). Molecular Model of Human CYP21 Based on Mammalian CYP2C5: Structural Features Correlate with Clinical Severity of Mutations Causing Congenital Adrenal Hyperplasia. Mol. Endocrinol.
20: 2946-2964
[Abstract][Full Text]
New, M. I.
(2006). Nonclassical 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
91: 4205-4214
[Abstract][Full Text]
Billerbeck, A. E. C., Mendonca, B. B., Pinto, E. M., Madureira, G., Arnhold, I. J. P., Bachega, T. A. S. S.
(2002). Three Novel Mutations in CYP21 Gene in Brazilian Patients with the Classical Form of 21-Hydroxylase Deficiency Due to a Founder Effect. J. Clin. Endocrinol. Metab.
87: 4314-4317
[Abstract][Full Text]
Lajic, S., Clauin, S., Robins, T., Vexiau, P., Blanche, H., Bellanne-Chantelot, C., Wedell, A.
(2002). Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism. J. Clin. Endocrinol. Metab.
87: 2824-2829
[Abstract][Full Text]
White, P. C., Speiser, P. W.
(2000). Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocr. Rev.
21: 245-291
[Abstract][Full Text]
New, M. I., Wilson, R. C.
(1999). Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. USA
96: 12790-12797
[Abstract][Full Text]
Witchel, S. F., Lee, P. A., Suda-Hartman, M., Trucco, M., Hoffman, E. P.
(1997). Evidence for a Heterozygote Advantage in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
82: 2097-2101
[Abstract][Full Text]
Tajima, T., Jun Nakae, K. F., Toyoura, T., Shimozawa, K., Kusuda, S., Goji, K., Nagashima, T., Cutler, G. B. Jr.
(1997). Molecular Basis of Nonclassical Steroid 21-Hydroxylase Deficiency Detected by Neonatal Mass Screening in Japan. J. Clin. Endocrinol. Metab.
82: 2350-2356
[Abstract][Full Text]
Oriola, J., Plensa, I., Machuca, I., Pavia, C., Rivera-Fillat, F.
(1997). Rapid screening method for detecting mutations in the 21-hydroxylase gene. Clin. Chem.
43: 557-561
[Abstract][Full Text]
Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., Luthman, H.
(1997). Synergistic Effect of Partially Inactivating Mutations in Steroid 21-Hydroxylase Deficiency. J. Clin. Endocrinol. Metab.
82: 194-199
[Abstract][Full Text]
Previous
